Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy?

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 4, 2007, Pages 361.e1-361.e4

  Odibo, Anthony O ^a   Sehdev, Harish M ^b   Stamilio, David M ^a   Cahill, Alison ^a   Dunn, Linda ^c   Macones, George A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c Delaware Valley Nephrology and Hypertension   (United States)

Author keywords

Down syndrome; nasal bone hypoplasia; screening efficiency

Indexed keywords

ANEUPLOIDY; ARTICLE; BIPARIETAL DISTANCE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; FETUS; GESTATIONAL AGE; HUMAN; HYPOPLASIA; NASAL BONE; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 34648825269     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.08.031     Document Type: Article

References (13)

1. Sonek J.D., and Nicolaides K.H. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 186 (2002) 139-141
2. Vintzileos A., Walters C., and Yeo L. Absent nasal bone in the prenatal detection of trisomy 21 in a high-risk population. Obstet Gynecol 101 (2003) 905-908
3. Bromley B., Lieberman E., Shipp T.D., and Benacerraf B. Fetal nasal bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 21 (2002) 1387-1394
4. Bunduki V., Ruano R., Miguelez J., Yoshizaki C.T., Kahhale S., and Zugaib M. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 21 (2003) 156-160
5. Cicero S., Sonek J.D., McKenna D.S., Croom C.S., Johnson L., and Nicolaides K.H. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 21 (2003) 15-18
6. Odibo A.O., Sehdev H.M., Dunn L., McDonald R., and Macones G.A. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol 104 (2004) 1229-1233
7. Odibo A.O., Sehdev H.M., Sproat L., et al. Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med 4 (2006) 437-441
8. Cusick W., Shevell T., Lupinacci C., Rivera J., and Crombleholme W. Nasal bone length hypoplasia based on multiples of the median in the second trimester confers a high risk for fetal trisomy 21 and 18. Am J Obstet Gynecol 193 (2005) S149
9. Gianferrari E.A., Benn P.A., Dries L., Brault K., Egan J.F.X., and Zelop C.M. Absent or shortened nasal bone length and the detection of Down syndrome in second-trimester fetuses. Obstet Gynecol 109 (2007) 371-375
10. Sonek J.D., Cicero S., Neiger R., and Nicolaides K.H. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 195 (2006) 1219-1230
11. Benoit B., and Chaoui R. Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in second-trimester screening for Down syndrome. Ultrasound Obstet Gynecol 25 (2005) 19-24
12. Lee W., DeVore G.R., Comstock C.H., et al. Nasal bone evaluation in fetuses with Down syndrome during the second and third trimesters of pregnancy. J Ultrasound Med 22 (2003) 55-60
13. Goncalves L.F., Espinoza J., Lee W., et al. Phenotypic characteristics of absent and hypoplastic nasal bones in fetuses with Down syndrome: description by 3-dimensional ultrasonography and clinical significance. J Ultrasound Med 23 (2004) 1619-1627